129 related articles for article (PubMed ID: 35652621)
1. Sodium butyrate inhibits oral squamous cell carcinoma proliferation and invasion by regulating the HDAC1/HSPB7 axis.
Yue HQ; Xu PF; Guo YD; Qi J; Liu RM; Li DH
Neoplasma; 2022 Sep; 69(5):1029-1040. PubMed ID: 35652621
[TBL] [Abstract][Full Text] [Related]
2. Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition.
Zang W; Liu J; Geng F; Liu D; Zhang S; Li Y; Pan Y
PeerJ; 2022; 10():e12991. PubMed ID: 35223210
[TBL] [Abstract][Full Text] [Related]
3. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
4. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.
Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):425-433. PubMed ID: 34409798
[TBL] [Abstract][Full Text] [Related]
5. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
[No Abstract] [Full Text] [Related]
6. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
7. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
8. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
Wang Y; Jiang Y; Chen L
J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
10. Mir-5100 Mediates Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells Via Targeting SCAI.
Wei Z; Lyu B; Hou D; Liu X
J Invest Surg; 2021 Aug; 34(8):834-841. PubMed ID: 31851859
[TBL] [Abstract][Full Text] [Related]
11. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
12. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
Wang X; Zhang Y; Zhang S; Duan L
Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
[TBL] [Abstract][Full Text] [Related]
13. Tumor Promoting Role of NRIP1 in Oral Squamous Cell Carcinoma: The Involvement of NSD2-Mediated Histone Methylation of DGCR8.
Zhang L; Hu G
Tohoku J Exp Med; 2023 Jul; 260(3):193-204. PubMed ID: 37045786
[TBL] [Abstract][Full Text] [Related]
14. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma.
Shen Q; Xiong P; Yang D; Chen L
Arch Oral Biol; 2022 Feb; 134():105336. PubMed ID: 34891100
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic circDHTKD1 promotes tumor growth and metastasis of oral squamous cell carcinoma in vitro and in vivo via upregulating miR-326-mediated GAB1.
Wu Z; He X; Chen S
Braz J Med Biol Res; 2021; 54(10):e10837. PubMed ID: 34287578
[TBL] [Abstract][Full Text] [Related]
16. ZNF677 inhibits oral squamous cell carcinoma growth and tumor stemness by regulating FOXO3a.
Zhang Z; Zhang Y; Hu X; Chen Y; Zhuang L; Zhang S
Hum Cell; 2023 Jul; 36(4):1464-1476. PubMed ID: 37129799
[TBL] [Abstract][Full Text] [Related]
17. Fructose-1,6-Bisphosphatase 2 Inhibits Oral Squamous Cell Carcinoma Tumorigenesis and Glucose Metabolism via Downregulation of c-Myc.
Wang L; Wang J; Shen Y; Zheng Z; Sun J
Oxid Med Cell Longev; 2022; 2022():6766787. PubMed ID: 35571245
[TBL] [Abstract][Full Text] [Related]
18. Expression and mechanism of long non-coding RNA HCG22 in oral squamous cell carcinoma.
Gao YQ; Shi PW; Shi WK; Liu YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Dec; 39(6):658-666. PubMed ID: 34859625
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma through KLF2 signal.
Kou Y; Zhang Y; Rong X; Yang P; Wang C; Zhou Q; Liu H; Liu B; Li M
J Oral Biosci; 2023 Dec; 65(4):347-355. PubMed ID: 37625505
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
